Bluejay Diagnostics Statistics
Total Valuation
BJDX has a market cap or net worth of $2.06 million. The enterprise value is -$2.19 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BJDX has 1.49 million shares outstanding.
| Current Share Class | 1.49M |
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +150.38% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 2.78% |
| Float | 1.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.56 |
| Quick Ratio | 4.27 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.04 |
Financial Efficiency
Return on equity (ROE) is -96.69% and return on invested capital (ROIC) is -57.74%.
| Return on Equity (ROE) | -96.69% |
| Return on Assets (ROA) | -48.66% |
| Return on Invested Capital (ROIC) | -57.74% |
| Return on Capital Employed (ROCE) | -125.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.85M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.88% in the last 52 weeks. The beta is 0.47, so BJDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -91.88% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 3.03 |
| Relative Strength Index (RSI) | 42.37 |
| Average Volume (20 Days) | 5,134,573 |
Short Selling Information
The latest short interest is 57,689, so 3.86% of the outstanding shares have been sold short.
| Short Interest | 57,689 |
| Short Previous Month | 35,648 |
| Short % of Shares Out | 3.86% |
| Short % of Float | 5.13% |
| Short Ratio (days to cover) | 1.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.72M |
| Pretax Income | -9.74M |
| Net Income | -19.96M |
| EBITDA | -6.65M |
| EBIT | -6.72M |
| Earnings Per Share (EPS) | -$30.02 |
Full Income StatementBalance Sheet
The company has $4.44 million in cash and $176,773 in debt, giving a net cash position of $4.27 million or $2.86 per share.
| Cash & Cash Equivalents | 4.44M |
| Total Debt | 176,773 |
| Net Cash | 4.27M |
| Net Cash Per Share | $2.86 |
| Equity (Book Value) | 5.29M |
| Book Value Per Share | 3.54 |
| Working Capital | 3.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.84 million and capital expenditures -$1,352, giving a free cash flow of -$6.85 million.
| Operating Cash Flow | -6.84M |
| Capital Expenditures | -1,352 |
| Free Cash Flow | -6.85M |
| FCF Per Share | -$4.58 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |